Trimas Corporation (TRS)
Trimas Corporation (TRS) is a diversified industrial company that designs, manufactures, and markets components, assemblies, and products primarily for the agriculture, transportation, and industrial markets. The company operates through various business segments, offering solutions that include precision-machined parts, vehicle accessories, and structural components. Trimas focuses on providing innovative, high-quality products and services to enhance the efficiency and performance of its customers' applications.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| August 12, 2025 | $0.04 | 2025-08-05 | 2025-08-05 |
| May 13, 2025 | $0.04 | 2025-05-06 | 2025-05-06 |
| March 7, 2025 | $0.04 | 2025-02-28 | 2025-02-28 |
| November 12, 2024 | $0.04 | 2024-11-05 | 2024-11-05 |
| August 13, 2024 | $0.04 | 2024-08-06 | 2024-08-06 |
Dividends Summary
- Trimas Corporation has issued 16 dividend payments over the past 4 years
- The most recent dividend was paid 39 days ago, on August 12, 2025
- The highest dividend payed out to investors during this period was $0.04 per share
- The average dividend paid during this period was $0.04 per share.
Company News
The global aircraft screw market is projected to grow at a CAGR of 3.9% from 2024 to 2032, reaching a size of $1.4 billion by 2032. The growth is driven by increasing aircraft production, demand for lightweight materials, and advancements in screw design.
The article discusses 5 top small-cap stocks that are Zacks Rank #1 (Strong Buy) or #2 (Buy) stocks, including Soundhound AI, Afya, Castle Biosciences, TriMas, and Immersion. The article provides an overview of each company's business, market cap, stock performance, and earnings growth outlook.
Upgrades For Avidity Biosciences Inc (NASDAQ:RNA), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. In the first quarter, Avidity Biosciences showed an EPS of $0.74, compared to $0.71 from the year-ago quarter. The current stock performance of Avidity Biosciences shows a 52-week-high of $25.74 and a 52-week-low of $9.88. Moreover, at the end of the last trading period, the closing price was at $10.82. Odeon Capital upgraded the previous rating for KeyCorp (NYSE:KEY) from Hold to Buy. For the first quarter, KeyCorp had an EPS of $0.30, compared to year-ago quarter EPS of $0.45. The stock has a 52-week-high of $20.30 and a 52-week-low of $8.54. At the end of the last trading period, KeyCorp closed at $9.82. Argus Research upgraded the previous rating for Rocket Companies Inc (NYSE:RKT) from Sell to Hold. For the first quarter, Rocket Companies had an EPS of $0.06, compared to year-ago quarter EPS of $0.15. At the moment, the stock has a 52-week-high of $11.38 and a 52-week-low of $5.97. Rocket Companies closed at $8.16 at the end of the last trading period. According to Vertical Research, the prior rating for Corteva Inc (NYSE:CTVA) was changed from Hold to Buy. Corteva earned $1.16 in the first quarter, compared to $0.97 in the year-ago quarter. The current stock performance of Corteva shows a 52-week-high of $68.42 and a 52-week-low of $50.03. Moreover, at the end of the last trading period, the closing price was at $56.97. Citigroup upgraded the previous rating for Knight-Swift Transportation Holdings Inc (NYSE:KNX) from Neutral to Buy. For the first quarter, Knight-Swift had an EPS of $0.73, compared to year-ago quarter EPS of $1.35. At the moment, the stock has a 52-week-high of $64.35 and a 52-week-low of $43.15. Knight-Swift closed at $54.59 at the end of the last trading period. BMO Capital upgraded the previous rating for TrueBlue Inc (NYSE:TBI) from Market Perform to Outperform. TrueBlue earned $0.06 in the first quarter, compared to $0.44 in the year-ago quarter. The stock has a 52-week-high of $23.00 and a 52-week-low of $14.20. At the end of the last trading period, TrueBlue closed at $16.04. For Azul SA (NYSE:AZUL), B of A Securities upgraded the previous rating of Underperform to Neutral. For the first quarter, Azul had an EPS of $0.99, compared to year-ago quarter EPS of $1.14. The current stock performance of Azul shows a 52-week-high of $13.81 and a 52-week-low of $3.82. Moreover, at the end of the last trading period, the closing price was at $8.40. For Norfolk Southern Corp (NYSE:NSC), Wells Fargo upgraded the previous rating of Equal-Weight to Overweight. For the first quarter, Norfolk Southern had an EPS of $3.32, compared to year-ago quarter EPS of $2.93. The stock has a 52-week-high of $264.17 and a 52-week-low of $196.33. At the end of the last trading period, Norfolk Southern closed at $217.74. According to Citigroup, the prior rating for Norfolk Southern Corp (NYSE:NSC) was changed from Neutral to Buy. For the first quarter, Norfolk Southern had an EPS of $3.32, compared to year-ago quarter EPS of $2.93. At the moment, the stock has a 52-week-high of $264.17 and a 52-week-low of $196.33. Norfolk Southern closed at $217.74 at the end of the last trading period. For Union Pacific Corp (NYSE:UNP), Citigroup upgraded the previous rating of Neutral to Buy. In the first quarter, Union Pacific showed an EPS of $2.54, compared to $2.57 from the year-ago quarter. The current stock performance of Union Pacific shows a 52-week-high of $242.35 and a 52-week-low of $183.69. Moreover, at the end of the last trading period, the closing price was at $198.97. UBS upgraded the previous rating for DraftKings Inc (NASDAQ:DKNG) from Neutral to Buy. In the first quarter, DraftKings showed an EPS of $0.87, compared to $1.14 from the year-ago quarter. At the moment, the stock has a 52-week-high of $25.34 and a 52-week-low of $10.52. DraftKings closed at $24.11 at the end of the last trading period. According to JP Morgan, the prior rating for AnaptysBio Inc (NASDAQ:ANAB) was changed from Underweight to Neutral. For the first quarter, AnaptysBio had an EPS of $1.58, compared to year-ago quarter EPS of $1.31. The stock has ...Full story available on Benzinga.com
TRS earnings call for the period ending September 30, 2021.